|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 611.34 USD | -3.79% |
|
+1.78% | -20.80% |
| Market Cap | 62.2B 53.86B 49.42B 46.5B 86.6B 5,927B 87.96B 587B 229B 2,866B 234B 228B 9,968B | P/E ratio 2026 * |
15.8x | P/E ratio 2027 * | 12.7x |
|---|---|---|---|---|---|
| Enterprise value | 54.28B 47.01B 43.13B 40.58B 75.59B 5,173B 76.77B 513B 200B 2,502B 204B 199B 8,700B | EV / Sales 2026 * |
3.42x | EV / Sales 2027 * | 2.93x |
| Free-Float |
72.33% | Yield 2026 * |
0.64% | Yield 2027 * | 0.72% |
Last Transcript: Regeneron Pharmaceuticals, Inc.
| 1 day | +2.15% | ||
| 1 week | +1.78% | ||
| Current month | -0.56% | ||
| 1 month | -14.48% | ||
| 3 months | -19.55% | ||
| 6 months | -13.07% | ||
| Current year | -20.80% |
| 1 week | 599 |  | 640.82 |
| 1 month | 591.52 | | 730.59 |
| Current year | 591.52 | | 821.11 |
| 1 year | 503.25 | | 821.11 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 01/01/2001 | |
| Chief Executive Officer | 73 | 08/01/1988 | |
| Director of Finance/CFO | 55 | 05/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 09/06/2023 | |
Michael Brown
BRD | Director/Board Member | 85 | 01/06/1991 |
Joseph Goldstein
BRD | Director/Board Member | 85 | 01/06/1991 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-01 | Sell | Director | -100 | 0.0001% | ||
| 04-01 | Sell | Director | 100 | 0.0001% | ||
| 03-02 | Sell | Director | 100 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.79% | +1.78% | +23.95% | -18.50% | 62.2B | |
| 0.00% | +5.11% | +62.62% | +204.69% | 57.37B | |
| -7.24% | +24.30% | +24.30% | +24.30% | 36.99B | |
| +1.59% | +7.47% | -59.26% | -67.42% | 33.6B | |
| -1.39% | +0.20% | +44.69% | -37.64% | 28.44B | |
| -1.70% | +5.28% | +46.34% | +63.62% | 20.11B | |
| +0.34% | +3.34% | +73.34% | -61.90% | 18.89B | |
| -0.68% | +1.47% | +43.78% | +99.37% | 16.26B | |
| -0.14% | -7.23% | -7.41% | +94.29% | 16.25B | |
| -0.35% | +3.08% | +74.44% | +313.57% | 13.2B | |
| Average | -0.61% | +0.13% | +32.68% | +61.44% | 30.33B | |
| Weighted average by Cap. | -0.47% | +0.20% | +30.17% | +51.28% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 15.88B 13.75B 12.62B 11.87B 22.11B 1,513B 22.46B 150B 58.37B 732B 59.63B 58.33B 2,545B | 17.55B 15.2B 13.95B 13.12B 24.44B 1,673B 24.82B 166B 64.52B 809B 65.91B 64.47B 2,813B |
| Net income | 4.09B 3.54B 3.25B 3.06B 5.69B 390B 5.78B 38.61B 15.03B 188B 15.35B 15.02B 655B | 5.13B 4.45B 4.08B 3.84B 7.15B 489B 7.26B 48.48B 18.87B 237B 19.27B 18.86B 823B |
| Net Debt | -7.91B -6.85B -6.29B -5.92B -11.02B -754B -11.19B -74.74B -29.09B -365B -29.71B -29.07B -1,268B | -10.69B -9.25B -8.49B -7.99B -14.88B -1,018B -15.11B -101B -39.28B -492B -40.12B -39.25B -1,712B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/06/26 | 611.34 $ | -3.79% | 1,259,234 |
| 05/06/26 | 635.45 $ | +1.07% | 975,793 |
| 04/06/26 | 628.73 $ | +1.58% | 974,745 |
| 03/06/26 | 618.95 $ | +2.66% | 986,685 |
| 02/06/26 | 602.92 $ | +0.38% | 1,067,006 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition